AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_43_Plasminogen Activator Inhibitor Type 1 in Liver Cirrhosis Patients and Non-Alcoholic Steatohepatitis under the Influence of Treatment with Human Albumin InfusionView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_42_Hepatic Resection for Hepatocelullar Carcinoma in Nigeria: a Sigle Centre Experiece from Northwest NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_41_Risks of developing hepatocellular carcinoma in patients with chronic HCV-infectionView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_39_Outcomes of Sorafenib therapy for hepatocellular carcinoma in EthiopiaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_40_Possible Role of Natural Killer Cells in Hepatitis C Virus Related Hepatocellular CarcinomaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_37_Prevalence de l’AgHBs et l’AcHCV chez les hemodialyses : cas de l’hopital general de Yaounde, CamerounView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_38_High HIV Viremia is associated with Increased Risk of Liver Cancers among poorly Viral Suppressed ART Initiators in South Western NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_36_Innate immune response in Plasmodium coinfection with HBV and HCV using complement C3, C4, and CD4+ T cellsView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_35_Hépatite virale B-Delta au Sénegal: aspects epidemiologiques, cliniques, paracliniques, therapeutiques et evolutifsView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_34_Séroprévalence de l’hépatite D chez les personnes atteintes d’hépatite B chronique à Lubumbashi (RDC)View Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_33_Seroprevalence and viral load of HBV, HCV and HIV co infected patients on ART in Bauchi, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_32_Clinical Features’ Frequency of Occult Hepatitis C Virus Infection (OCI) in People Living with HIV / AIDS at Yaoundé Central Hospital, CameroonView Abstract
